PK Study of Pregabalin GLARS Tablet 150mg and IR Formulation After Multiple Dosing Under Fed Condition in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

July 31, 2014

Study Completion Date

November 30, 2014

Conditions

Healthy

Interventions

DRUG

Pregabalin 150mg

GLA5PR GLARS tablet 150mg/day(Pregabalin 150mg once a day, after meal) for three days

DRUG

Pregabalin 75mg

Lyrica Capsule 150mg/day(Pregabalin 75mg twice a day, after meal) for three days

Trial Locations (1)

Chonbuk National University Hospital, Jeonju